4-hydroxycyclophosphamide has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebi, H; Fujiki, Y; Itoh, K; Kanada, Y; Komagata, S; Minami, H; Mukai, H; Nakajima, M; Yokoi, T | 1 |
| Atzpodien, J; Clarkson, BD; Colvin, OM; Gulati, SC; Jain, K; Langleben, A; Ng, RP; Shimazaki, C; Yopp, J | 1 |
2 other study(ies) available for 4-hydroxycyclophosphamide and Lymphoma
| Article | Year |
|---|---|
Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients.
Topics: Adult; Aged; Alleles; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Base Sequence; Breast Neoplasms; Cyclophosphamide; Cytochrome P-450 CYP2B6; DNA, Neoplasm; Female; Gene Frequency; Genotype; Humans; Introns; Japan; Lymphoma; Male; Middle Aged; Oxidoreductases, N-Demethylating; Pharmacogenetics; Polymorphism, Genetic; Promoter Regions, Genetic | 2007 |
Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow.
Topics: Antineoplastic Agents; B-Lymphocytes; Bleomycin; Bone Marrow; Cell Line; Cell Separation; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Mechlorethamine; Vincristine | 1988 |